The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

Affiliations

¹ Nuclear Medicine Division, Foundation IRCCS Istituto Nazionale Tumori, Milan, Italy. carlo.chiesa@istitutotumori.mi.it.
² Department of Medical Radiation Physics, Lund University, Lund, Sweden.
³ Joint Department of Physics, Royal Marsden Hospital & Institute of Cancer Research, Sutton, UK.
⁴ Nuclear Medicine, Molecular Imaging, Radiotherapy and Oncology Unit (MIRO), IECR, Université Catholique de Louvain, Brussels, Belgium.
⁵ Department of Basic Medical Sciences, Division of Medical Physics, Ghent University, Ghent, Belgium.
⁶ Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany.
⁷ Department of Radiology and Nuclear Medicine, Radboud University Medical Centre (RadboudUMC), Nijmegen, The Netherlands.
⁸ LUNAM Université, Oniris, «AMaROC», Nantes, France.
⁹ Centre de Recherches en Cancérologie de Toulouse, Université Paul Sabatier, UMR 1037 INSERM, Toulouse, France.
¹⁰ Laboratory of Medical Physics and Expert Systems, National Cancer Institute Regina Elena, Rome, Italy.
¹¹ Department of Radiology and Nuclear Medicine Erasmus MC, Rotterdam, The Netherlands.

Editorial

C Chiesa et al. Eur J Nucl Med Mol Imaging. 2017 Oct.

. 2017 Oct;44(11):1783-1786.

doi: 10.1007/s00259-017-3707-3. Epub 2017 May 24.

¹ Nuclear Medicine Division, Foundation IRCCS Istituto Nazionale Tumori, Milan, Italy. carlo.chiesa@istitutotumori.mi.it.
² Department of Medical Radiation Physics, Lund University, Lund, Sweden.
³ Joint Department of Physics, Royal Marsden Hospital & Institute of Cancer Research, Sutton, UK.
⁴ Nuclear Medicine, Molecular Imaging, Radiotherapy and Oncology Unit (MIRO), IECR, Université Catholique de Louvain, Brussels, Belgium.
⁵ Department of Basic Medical Sciences, Division of Medical Physics, Ghent University, Ghent, Belgium.
⁶ Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany.
⁷ Department of Radiology and Nuclear Medicine, Radboud University Medical Centre (RadboudUMC), Nijmegen, The Netherlands.
⁸ LUNAM Université, Oniris, «AMaROC», Nantes, France.
⁹ Centre de Recherches en Cancérologie de Toulouse, Université Paul Sabatier, UMR 1037 INSERM, Toulouse, France.
¹⁰ Laboratory of Medical Physics and Expert Systems, National Cancer Institute Regina Elena, Rome, Italy.
¹¹ Department of Radiology and Nuclear Medicine Erasmus MC, Rotterdam, The Netherlands.

No abstract available

Comment in

From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
Flux GD, Sjogreen Gleisner K, Chiesa C, Lassmann M, Chouin N, Gear J, Bardiès M, Walrand S, Bacher K, Eberlein U, Ljungberg M, Strigari L, Visser E, Konijnenberg MW. Flux GD, et al. Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):152-154. doi: 10.1007/s00259-017-3859-1. Epub 2017 Oct 27. Eur J Nucl Med Mol Imaging. 2018. PMID: 29080096 Free PMC article. No abstract available.